StockData
Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) KPIs and segments

ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.02 (-6.12%)

Close on Nov 17, 2026Market cap $6.04MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Actuate Therapeutics's business

Coming soon

This tab will track the numbers specific to Actuate Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?